FAVRE; Christine

Patent Applications and Registrations

Patent applications and USPTO patent grants for FAVRE; Christine.The latest application filed is for "suppression of bone cancer-induced allodynia".

Company Profile

2.8.8

FAVRE; Christine - Wrexham GB
Favre; Christine - Saint Maurice Montcouronne FR
- Saint Maurice Montcouronne FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Suppression of Bone Cancer-induced Allodynia App 20210205422 - KALINICHEV; Mikhail ; et al.	2021-07-08
Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy Grant 9,259,458 - Favre , et al. February 16, 2	2016-02-16
Simultaneous, separate or sequential therapeutic use of at least one botulinum neurotoxin and of at least one opiate derivative Grant 9,080,220 - Auguet , et al. July 14, 2	2015-07-14
Use of at least one botulinum neurotoxin for treating the pain induced by therapeutic treatments for the AIDS virus Grant 8,921,322 - Favre , et al. December 30, 2	2014-12-30
Use of at least one botulinum neurotoxin for treating the pain induced by therapeutic treatments for the AIDS virus Grant 08921322 -	2014-12-30
Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy Grant 8,784,841 - Favre , et al. July 22, 2	2014-07-22
Therapeutic Use of Botulinum Neurotoxin in the Treatment of pain associated with diabetic neuropathy App 20140154781 - FAVRE; Christine ; et al.	2014-06-05
Therapeutic use of at least one botulinum neurotoxin in the treatment of pain induced by at least one anti-neoplastic agent Grant 8,273,359 - Favre , et al. September 25, 2	2012-09-25
Therapeutic Use Of At Least One Botulinum Neurotoxin In The Treatment Of Pain Associated With Diabetic Neuropathy App 20110038893 - Favre; Christine ; et al.	2011-02-17
Therapeutic use of at least one botulinum neurotoxin in the treatment of pain induced by at least one anti-neoplastic agent App 20100068231 - Favre; Christine ; et al.	2010-03-18
Use Of At Least One Botulinum Neurotoxin For Treating The Pain Induced By Therapeutic Treatments For The Aids Virus App 20100029566 - Favre; Christine ; et al.	2010-02-04
Painkilling Association Comprising A Dihydroimidazopyrazine Derivative App 20090270400 - Auguet; Michel ; et al.	2009-10-29
Use Of A Dihydroimidazopyrazoine Derivative For Treating Or Preventing Pain App 20090270401 - Auguet; Michel ; et al.	2009-10-29
Simultaneous, Separate Or Sequential Therapeutic Use Of At Least One Botulinum Neurotoxin And Of At Least One Opiate Derivative App 20090232851 - Auguet; Michel ; et al.	2009-09-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.